Ifytrox-TB 250mg/31.25mg Injection
Marketer
Sanify Healthcare Pvt Ltd
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Ifytrox-TB 250mg/31.25mg Injection
Combiflox-TB, a 250mg/31.25mg injectable combination drug, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely by a healthcare provider; strict adherence to the prescribed regimen is vital, even with symptom improvement, to ensure efficacy. Premature cessation may compromise treatment. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt medical assistance. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Alcohol consumption should be avoided due to potential additive drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration promote recovery. Monitoring via laboratory tests may be implemented to assess treatment efficacy.
Uses of Ifytrox-TB 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ifytrox-TB 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ifytrox-TB 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Ifytrox-TB 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Ifytrox-TB 250mg/31.25mg Injection works:
Ifytrox-TB Injection (250mg/31.25mg) combines ceftazidime, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. Ceftazidime's antibiotic action disrupts bacterial cell wall formation, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ifytrox-TB 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifytrox-TB (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ifytrox-TB 250mg/31.25mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
The administration of Ifytrox-TB 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Ifytrox-TB 250mg/31.25mg Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Ifytrox-TB 250mg/31.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ifytrox-TB 250mg/31.25mg Injection :
Should you forget a dose of Ifytrox-TB 250mg/31.25mg Injection, seek medical advice immediately.
Facts to Know About Ifytrox-TB 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently